Real-time enrollment status for this locally advanced urothelial carcinoma clinical trial
Current Status
Recruiting
Checked: October 21, 2026 at 10:10 PM UTC
| NCT Number | NCT06524544 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced Urothelial Carcinoma |
| Phase | PHASE3 |
| Target Enrollment | 320 participants |
| Active Locations | 162 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 5, 2026 (2 weeks ago) |
As of October 21, 2026: Clinical trial NCT06524544 is currently recruiting participants. This phase3 study for locally advanced urothelial carcinoma is actively seeking new participants at 162 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06524544 is actively recruiting participants as of October 21, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 162 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06524544 was last updated 2 weeks ago (October 5, 2026). HelloStudys verifies this status automatically.